Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.360
-0.030 (-2.16%)
At close: Dec 5, 2025, 4:00 PM EST
1.350
-0.010 (-0.74%)
After-hours: Dec 5, 2025, 6:11 PM EST
Rein Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -58.89 | -62.88 | -15.73 | -27.33 | -26.16 | -21.16 | |
| Depreciation & Amortization | 0 | 0.06 | 0.12 | 0.17 | 0.12 | 0.16 | |
| Loss (Gain) From Sale of Assets | - | - | -0.04 | - | -0.07 | -0.09 | |
| Asset Writedown & Restructuring Costs | 37 | 37 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | - | - | 0.03 | -0.21 | 0.24 | -0.01 | |
| Stock-Based Compensation | 2.1 | 1.12 | 1.19 | 2.08 | 2.26 | 1.89 | |
| Other Operating Activities | 0.4 | - | - | - | -0.39 | - | |
| Change in Accounts Payable | 3.04 | -0.28 | -4.98 | 0.51 | -0.39 | 0.12 | |
| Change in Other Net Operating Assets | -3.06 | 4.25 | -0.4 | -0.09 | 0.63 | -1.4 | |
| Operating Cash Flow | -20.95 | -22.29 | -19.81 | -24.87 | -23.75 | -20.48 | |
| Capital Expenditures | - | - | - | - | -0.16 | -0.01 | |
| Sale of Property, Plant & Equipment | - | - | 0.04 | - | 0.07 | 0.21 | |
| Cash Acquisitions | - | - | -0.1 | - | - | - | |
| Investment in Securities | - | - | 16.25 | 26.46 | -35.83 | 6.21 | |
| Investing Cash Flow | - | - | 16.2 | 26.46 | -35.92 | 6.41 | |
| Long-Term Debt Issued | - | - | 15.79 | - | - | 0.39 | |
| Net Debt Issued (Repaid) | 1.9 | - | 15.79 | - | - | 0.39 | |
| Issuance of Common Stock | 1.99 | 10.79 | - | - | 59.16 | 15.41 | |
| Other Financing Activities | 3.47 | 7.03 | - | - | -3.51 | - | |
| Financing Cash Flow | 7.35 | 17.82 | 15.79 | - | 55.66 | 15.8 | |
| Foreign Exchange Rate Adjustments | -0.03 | - | -0.06 | - | - | - | |
| Net Cash Flow | -13.63 | -4.47 | 12.12 | 1.59 | -4.01 | 1.74 | |
| Free Cash Flow | -20.95 | -22.29 | -19.81 | -24.87 | -23.91 | -20.48 | |
| Free Cash Flow Per Share | -0.89 | -1.24 | -4.31 | -5.48 | -5.38 | -11.75 | |
| Levered Free Cash Flow | -12.76 | -14.82 | -7.62 | -14.48 | -13.5 | -13.61 | |
| Unlevered Free Cash Flow | -12.76 | -14.82 | -7.62 | -14.48 | -13.5 | -13.61 | |
| Change in Working Capital | -1.57 | 2.41 | -5.38 | 0.42 | 0.24 | -1.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.